186 related articles for article (PubMed ID: 37166019)
1. Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.
Chung J; Sahelijo N; Maruyama T; Hu J; Panitch R; Xia W; Mez J; Stein TD; ; Saykin AJ; Takeyama H; Farrer LA; Crane PK; Nho K; Jun GR
Alzheimers Dement; 2023 Nov; 19(11):5173-5184. PubMed ID: 37166019
[TBL] [Abstract][Full Text] [Related]
2. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.
Groot C; Grothe MJ; Mukherjee S; Jelistratova I; Jansen I; van Loenhoud AC; Risacher SL; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Gryglewski G; Lanzenberger R; Pijnenburg YAL; Barkhof F; Scheltens P; van der Flier WM; Crane PK; Ossenkoppele R
Neuroimage Clin; 2021; 30():102660. PubMed ID: 33895633
[TBL] [Abstract][Full Text] [Related]
4. The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer's Disease.
Qiu WY; Yang Q; Zhang W; Wang N; Zhang D; Huang Y; Ma C
Curr Alzheimer Res; 2018 Mar; 15(5):462-473. PubMed ID: 29110614
[TBL] [Abstract][Full Text] [Related]
5. Pathology of clinical and preclinical Alzheimer's disease.
Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR
Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.
Ohm DT; Fought AJ; Rademaker A; Kim G; Sridhar J; Coventry C; Gefen T; Weintraub S; Bigio E; Mesulam MM; Rogalski E; Geula C
Brain Pathol; 2020 Mar; 30(2):332-344. PubMed ID: 31446630
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.
Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Chen Y; Chen K; Chao MV; Counts SE; Mufson EJ
Neurobiol Dis; 2019 Dec; 132():104540. PubMed ID: 31349032
[TBL] [Abstract][Full Text] [Related]
8. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease.
Yang HS; Teng L; Kang D; Menon V; Ge T; Finucane HK; Schultz AP; Properzi M; Klein HU; Chibnik LB; Schneider JA; Bennett DA; Hohman TJ; Mayeux RP; Johnson KA; De Jager PL; Sperling RA
Nat Commun; 2023 Nov; 14(1):7659. PubMed ID: 38036535
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.
Li QS; De Muynck L
Brain Behav Immun Health; 2021 May; 13():100227. PubMed ID: 34589742
[TBL] [Abstract][Full Text] [Related]
10. Hypothesis review: Alzheimer's overture guidelines.
Ferrer I
Brain Pathol; 2023 Jan; 33(1):e13122. PubMed ID: 36223647
[TBL] [Abstract][Full Text] [Related]
11. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
[TBL] [Abstract][Full Text] [Related]
12. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.
Zhang M; Ganz AB; Rohde S; Rozemuller AJM; Bank NB; Reinders MJT; Scheltens P; Hulsman M; Hoozemans JJM; Holstege H
Alzheimers Dement; 2023 Jul; 19(7):2831-2841. PubMed ID: 36583547
[TBL] [Abstract][Full Text] [Related]
13. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
[TBL] [Abstract][Full Text] [Related]
14. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.
Tan CH; Bonham LW; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Yokoyama JS; Rabinovici GD; Miller BL; Yaffe K; Schellenberg GD; Kauppi K; Holland D; McEvoy LK; Kukull WA; Tosun D; Weiner MW; Sperling RA; Bennett DA; Hyman BT; Andreassen OA; Dale AM; Desikan RS;
Brain; 2019 Feb; 142(2):460-470. PubMed ID: 30689776
[TBL] [Abstract][Full Text] [Related]
15. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
[TBL] [Abstract][Full Text] [Related]
16. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
Nelson PT; Abner EL; Schmitt FA; Kryscio RJ; Jicha GA; Santacruz K; Smith CD; Patel E; Markesbery WR
J Neuropathol Exp Neurol; 2009 Jul; 68(7):774-84. PubMed ID: 19535994
[TBL] [Abstract][Full Text] [Related]
17. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease.
Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT;
Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486
[TBL] [Abstract][Full Text] [Related]
18. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
Jellinger KA
J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
[TBL] [Abstract][Full Text] [Related]
19. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
